Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
Bangladesh
International Centre for Diarrheal Disease Research, Dhaka Malawi
Queen Elizabeth Central Hospital, Blantyre